Company: Diurnal (DNL)
Date: 27th April 2021
Time: 5pm – 6pm
Format: Webinar
Presenter: Martin Whitaker – CEO
Registration: click here
Company Information: Founded in 2004, Diurnal is a UK-headquartered, European specialty pharma company developing hormone therapeutics for the global market for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency and hypogonadism. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.
Registration: click here